Literature DB >> 7573123

Cytogenetic and molecular analysis of a ring (21) in a patient with partial trisomy 21 and megakaryocytic leukemia.

C G Palmer1, J L Blouin, M J Bull, P Breitfeld, G H Vance, T Van Meter, D D Weaver, N A Heerema, S G Colbern, J R Korenberg.   

Abstract

We describe a patient with an asymmetric double ring 21 in mosaic form, 45,XX, -21/46, XX, -21, +r(21), who has limited manifestations of Down syndrome and who developed acute myelofibrosis and megakaryocytic leukemia (AMKL), FAB M7, a hematologic disorder particularly common in Down syndrome patients. In situ hybridization studies, gene dosage, and DNA polymorphism analysis showed that the ring chromosome carries a duplicated region which extends from D21S406 on the centromeric side and includes marker D21S3 on the telomeric side. FISH studies indicate two sizes of ring 21 in the patient. The origin of the supernumerary chromosome 21 in the proband was paternal; furthermore, the r(21) probably was formed postzygotically. Included in the duplicated segment are the candidate genes for leukemia AML-1, ETS, and ERG. The potential significance of disomic homozygosity of loci on 21q in M7 megakaryocytic leukemia is discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7573123     DOI: 10.1002/ajmg.1320570403

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

Review 1.  Ring chromosomes: from formation to clinical potential.

Authors:  Inna E Pristyazhnyuk; Aleksei G Menzorov
Journal:  Protoplasma       Date:  2017-09-12       Impact factor: 3.356

2.  Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy.

Authors:  Kazuko Kudo; Asahito Hama; Seiji Kojima; Ruriko Ishii; Akira Morimoto; Fumio Bessho; Shosuke Sunami; Naoyuki Kobayashi; Akitoshi Kinoshita; Yuri Okimoto; Akio Tawa; Ichiro Tsukimoto
Journal:  Int J Hematol       Date:  2010-03-18       Impact factor: 2.490

3.  Biological and clinical features of trisomy 21 in adult patients with acute myeloid leukemia.

Authors:  Paolo Strati; Naval Daver; Farhad Ravandi; Naveen Pemmaraju; Sherry Pierce; Guillermo Garcia-Manero; Aziz Nazha; Tapan Kadia; Elias Jabbour; Gautam Borthakur; Stefan Faderl; Alfonso Quintas-Cardama; Hagop Kantarjian; Jorge Cortes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.